Concepts (107)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Urology | 4 | 2023 | 400 | 0.950 |
Why?
|
Nephrectomy | 4 | 2013 | 937 | 0.770 |
Why?
|
Publishing | 3 | 2016 | 833 | 0.620 |
Why?
|
Adrenalectomy | 2 | 2010 | 346 | 0.550 |
Why?
|
Laparoscopy | 4 | 2012 | 2036 | 0.460 |
Why?
|
Testicular Diseases | 1 | 2014 | 73 | 0.450 |
Why?
|
Scrotum | 1 | 2014 | 116 | 0.440 |
Why?
|
Granuloma, Plasma Cell | 1 | 2014 | 80 | 0.430 |
Why?
|
Biomedical Research | 3 | 2016 | 3429 | 0.380 |
Why?
|
Adrenal Gland Diseases | 1 | 2010 | 141 | 0.320 |
Why?
|
Varicocele | 3 | 2013 | 75 | 0.280 |
Why?
|
Pyelonephritis, Xanthogranulomatous | 1 | 2006 | 5 | 0.280 |
Why?
|
Internship and Residency | 3 | 2016 | 5882 | 0.280 |
Why?
|
Kidney Neoplasms | 3 | 2013 | 4251 | 0.260 |
Why?
|
Carcinoma, Renal Cell | 2 | 2012 | 3165 | 0.250 |
Why?
|
Robotics | 1 | 2010 | 819 | 0.210 |
Why?
|
Adrenal Gland Neoplasms | 1 | 2008 | 732 | 0.200 |
Why?
|
Urodynamics | 1 | 2020 | 346 | 0.150 |
Why?
|
Urethra | 1 | 2020 | 405 | 0.150 |
Why?
|
Neoplasm Staging | 1 | 2012 | 11121 | 0.150 |
Why?
|
Testosterone | 3 | 2013 | 2472 | 0.140 |
Why?
|
Urologic Neoplasms | 1 | 2017 | 314 | 0.110 |
Why?
|
Accreditation | 1 | 2016 | 473 | 0.110 |
Why?
|
Semen Analysis | 2 | 2013 | 236 | 0.100 |
Why?
|
Vasovasostomy | 1 | 2011 | 6 | 0.100 |
Why?
|
Testicular Neoplasms | 1 | 2017 | 799 | 0.090 |
Why?
|
Urologic Surgical Procedures, Male | 1 | 2010 | 78 | 0.090 |
Why?
|
Nomograms | 1 | 2011 | 230 | 0.090 |
Why?
|
Fibrosis | 2 | 2014 | 2049 | 0.090 |
Why?
|
Pain | 2 | 2020 | 5073 | 0.070 |
Why?
|
Progesterone Reductase | 1 | 2005 | 14 | 0.070 |
Why?
|
Steroid Isomerases | 1 | 2005 | 19 | 0.060 |
Why?
|
Cholesterol Side-Chain Cleavage Enzyme | 1 | 2005 | 28 | 0.060 |
Why?
|
Male | 15 | 2023 | 360842 | 0.060 |
Why?
|
Telemedicine | 1 | 2023 | 3052 | 0.060 |
Why?
|
Ouabain | 1 | 2005 | 247 | 0.060 |
Why?
|
Anxiety | 1 | 2020 | 4573 | 0.060 |
Why?
|
Education, Medical | 1 | 2016 | 1725 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2014 | 64684 | 0.060 |
Why?
|
Neovascularization, Pathologic | 1 | 2013 | 2644 | 0.050 |
Why?
|
Adrenal Glands | 1 | 2005 | 552 | 0.050 |
Why?
|
Sodium-Potassium-Exchanging ATPase | 1 | 2005 | 477 | 0.050 |
Why?
|
Decision Making | 1 | 2016 | 3929 | 0.050 |
Why?
|
Kidney Diseases | 1 | 2013 | 2091 | 0.050 |
Why?
|
Humans | 18 | 2023 | 761572 | 0.050 |
Why?
|
Multienzyme Complexes | 1 | 2005 | 666 | 0.050 |
Why?
|
Microsurgery | 3 | 2011 | 795 | 0.050 |
Why?
|
Female | 10 | 2023 | 392686 | 0.050 |
Why?
|
Hypothalamus | 1 | 2005 | 999 | 0.040 |
Why?
|
Retrospective Studies | 6 | 2023 | 80646 | 0.040 |
Why?
|
Infertility, Male | 2 | 2013 | 395 | 0.040 |
Why?
|
Length of Stay | 1 | 2012 | 6426 | 0.040 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2013 | 4026 | 0.040 |
Why?
|
Kidney | 1 | 2013 | 7047 | 0.040 |
Why?
|
Feasibility Studies | 1 | 2006 | 5247 | 0.030 |
Why?
|
Adenocarcinoma | 1 | 2013 | 6346 | 0.030 |
Why?
|
Aged | 5 | 2013 | 169310 | 0.030 |
Why?
|
Electromyography | 1 | 2020 | 1394 | 0.030 |
Why?
|
Adult | 7 | 2020 | 221203 | 0.030 |
Why?
|
Prostatic Neoplasms | 1 | 2017 | 11122 | 0.030 |
Why?
|
Developed Countries | 1 | 2017 | 449 | 0.030 |
Why?
|
Skin Neoplasms | 1 | 2013 | 5821 | 0.030 |
Why?
|
Rats, Nude | 1 | 2013 | 105 | 0.030 |
Why?
|
New York | 1 | 2016 | 874 | 0.030 |
Why?
|
Time Factors | 1 | 2015 | 39970 | 0.030 |
Why?
|
Middle Aged | 5 | 2013 | 220920 | 0.030 |
Why?
|
Arteriolosclerosis | 1 | 2013 | 21 | 0.030 |
Why?
|
Sclerosis | 1 | 2013 | 210 | 0.030 |
Why?
|
Inguinal Canal | 1 | 2010 | 71 | 0.020 |
Why?
|
Kidney Function Tests | 1 | 2013 | 679 | 0.020 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2009 | 9280 | 0.020 |
Why?
|
Hypertension | 2 | 2013 | 8540 | 0.020 |
Why?
|
Sperm Count | 1 | 2010 | 229 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2013 | 2016 | 0.020 |
Why?
|
Glomerulosclerosis, Focal Segmental | 1 | 2013 | 335 | 0.020 |
Why?
|
Sperm Motility | 1 | 2010 | 266 | 0.020 |
Why?
|
Child, Preschool | 2 | 2023 | 42230 | 0.020 |
Why?
|
Creatinine | 1 | 2013 | 1899 | 0.020 |
Why?
|
Cicatrix | 1 | 2013 | 798 | 0.020 |
Why?
|
Hypogonadism | 1 | 2013 | 798 | 0.020 |
Why?
|
Diabetic Nephropathies | 1 | 2013 | 973 | 0.020 |
Why?
|
Postoperative Period | 1 | 2010 | 1814 | 0.020 |
Why?
|
PC12 Cells | 1 | 2005 | 317 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2010 | 3416 | 0.010 |
Why?
|
Rats | 2 | 2013 | 23741 | 0.010 |
Why?
|
Child | 2 | 2023 | 80156 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2010 | 6228 | 0.010 |
Why?
|
Databases, Factual | 1 | 2017 | 7967 | 0.010 |
Why?
|
Infant | 1 | 2023 | 36192 | 0.010 |
Why?
|
Skin | 1 | 2013 | 4484 | 0.010 |
Why?
|
Incidence | 1 | 2017 | 21355 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2013 | 10448 | 0.010 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2013 | 8552 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2005 | 3778 | 0.010 |
Why?
|
RNA Interference | 1 | 2005 | 2832 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2005 | 6075 | 0.010 |
Why?
|
Prospective Studies | 1 | 2020 | 54426 | 0.010 |
Why?
|
Age Factors | 1 | 2010 | 18398 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 59255 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 22176 | 0.010 |
Why?
|
Prognosis | 1 | 2013 | 29629 | 0.010 |
Why?
|
Adolescent | 1 | 2020 | 88324 | 0.010 |
Why?
|
RNA, Messenger | 1 | 2005 | 12794 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 39107 | 0.010 |
Why?
|
Animals | 2 | 2013 | 168467 | 0.000 |
Why?
|
Cohort Studies | 1 | 2010 | 41493 | 0.000 |
Why?
|
Risk Factors | 1 | 2011 | 74213 | 0.000 |
Why?
|
Concepts
(107)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(6)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_